BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32414668)

  • 1. Silencing DVL3 defeats MTX resistance and attenuates stemness via Notch Signaling Pathway in colorectal cancer.
    Zhao Q; Zhuang K; Han K; Tang H; Wang Y; Si W; Yang Z
    Pathol Res Pract; 2020 Aug; 216(8):152964. PubMed ID: 32414668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt/β-catenin/c-Myc/SOX2 pathway in colorectal cancer.
    Li Z; Yang Z; Liu W; Zhu W; Yin L; Han Z; Xian Y; Wen J; Tang H; Lin X; Yang Y; Wang J; Zhang K
    J Transl Med; 2023 May; 21(1):302. PubMed ID: 37147666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
    Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
    Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXM1/DVL2/Snail axis drives metastasis and chemoresistance of colorectal cancer.
    Yang Y; Jiang H; Li W; Chen L; Zhu W; Xian Y; Han Z; Yin L; Liu Y; Wang Y; Pan K; Zhang K
    Aging (Albany NY); 2020 Dec; 12(23):24424-24440. PubMed ID: 33291076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
    Shi L; Xi J; Xu X; Peng B; Zhang B
    Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma.
    Tsui YM; Sze KM; Tung EK; Ho DW; Lee TK; Ng IO
    Oncotarget; 2017 Jun; 8(24):39430-39442. PubMed ID: 28455968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of PER3 Inhibits Self-Renewal Capability and Chemoresistance of Colorectal Cancer Stem-Like Cells via Inhibition of Notch and β-Catenin Signaling.
    Zhang F; Sun H; Zhang S; Yang X; Zhang G; Su T
    Oncol Res; 2017 May; 25(5):709-719. PubMed ID: 27983919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling.
    Jin Y; Wang M; Hu H; Huang Q; Chen Y; Wang G
    Int J Biol Macromol; 2018 Oct; 117():445-453. PubMed ID: 29852230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dishevelled Segment Polarity Protein 3 (DVL3) Induced by Bacterial LPS Promotes the Proliferation and Migration of Prostate Cancer Cells through the TLR4 Pathway.
    Zhang Y; Lin N; Liu X; Yao T
    Arch Esp Urol; 2024 Mar; 77(2):193-201. PubMed ID: 38583012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H19 mediates methotrexate resistance in colorectal cancer through activating Wnt/β-catenin pathway.
    Wu KF; Liang WC; Feng L; Pang JX; Waye MM; Zhang JF; Fu WM
    Exp Cell Res; 2017 Jan; 350(2):312-317. PubMed ID: 27919747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Notch pathway in colorectal cancer.
    Vinson KE; George DC; Fender AW; Bertrand FE; Sigounas G
    Int J Cancer; 2016 Apr; 138(8):1835-42. PubMed ID: 26264352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the aqueous extract of Aloe vera and its two active components on the Wnt/β-catenin and Notch signaling pathways in colorectal cancer cells.
    Peng C; Zhang W; Dai C; Li W; Shen X; Yuan Y; Yan L; Zhang W; Yao M
    J Ethnopharmacol; 2019 Oct; 243():112092. PubMed ID: 31319122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
    Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
    Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Notch and Wnt signaling for chemoresistance of colorectal cancer cells HCT116.
    Kukcinaviciute E; Jonusiene V; Sasnauskiene A; Dabkeviciene D; Eidenaite E; Laurinavicius A
    J Cell Biochem; 2018 Jul; 119(7):5913-5920. PubMed ID: 29637602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
    Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
    Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
    Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
    Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway.
    Xian D; Zhao Y
    J Cell Mol Med; 2019 Jun; 23(6):3808-3823. PubMed ID: 30997746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMPK activators suppress breast cancer cell growth by inhibiting DVL3-facilitated Wnt/β-catenin signaling pathway activity.
    Zou YF; Xie CW; Yang SX; Xiong JP
    Mol Med Rep; 2017 Feb; 15(2):899-907. PubMed ID: 28035400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
    Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
    J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.